PRECORNEAL RESIDENCE TIME IN HUMANS OF SODIUM HYALURONATE AS MEASURED BY GAMMA-SCINTIGRAPHY

被引:31
作者
GURNY, R
RYSER, JE
TABATABAY, C
MARTENET, M
EDMAN, P
CAMBER, O
机构
[1] UNIV GENEVA,HOP CANTONAL,DEPT NUCL MED,CH-1211 GENEVA 4,SWITZERLAND
[2] PHARM LEO THERAPEUT AB,DEPT PHARMACEUT RES & DEV,UPPSALA,SWEDEN
[3] UNIV GENEVA,HOP CANTONAL,DEPT OPHTHALMOL,CH-1211 GENEVA 4,SWITZERLAND
关键词
D O I
10.1007/BF00918481
中图分类号
R77 [眼科学];
学科分类号
100212 ;
摘要
The aim of the present study was to quantify in man the distribution and clearance of two aqueous sodium hyaluronate (SH) solutions of 0.125% and 0.250% after the administration of 25 μl onto the cornea. Isotonic phosphate buffer (PB) was used as a reference instillation. No systemic or local medication was given to the seven 18- to 30-year-old, healthy male volunteers. A detailed evaluation of the anterior segment of the eye, as well as a Schirmer test and a break-up time measurement, yielded results within the normal range. The clearance of 0.125% and 0.250% SH solutions radiolabelled with sodium pertechnetate Tc-99m was measured by gamma scintigraphy and compared with that of a PB solution tagged with the same radiolabel. There was no statistically significant difference between the quantities of 0.125% SH and PB solutions remaining in the precorneal space at 20 min (paired t-test, P=0.78, n=7). However, in comparing the 0.250% SH with the PB solution, we observed a statistically significant difference (P=0.01, n=7) in the amount remaining in the precorneal space after the same interval. Actually, 53% of the radiolabelled 0.250% SH solution remained on the cornea as compared with 30% for the 0.125% SH solution and 18.3% for the PB solution. These results suggest that an SH solution of 0.250% might have a prolonged residence time on the precorneal surface, and that SH could therefore be used as an additive in various drug-release systems for the eye. © 1990 Springer-Verlag.
引用
收藏
页码:510 / 512
页数:3
相关论文
共 15 条
  • [1] BARETT TW, 1976, BIOSYSTEMS, V8, P103
  • [2] CAMBER O, 1985, ACTA PHARM SUEC, V22, P315
  • [3] INFLUENCE OF SODIUM HYALURONATE ON THE MEIOTIC EFFECT OF PILOCARPINE IN RABBITS
    CAMBER, O
    EDMAN, P
    GURNY, R
    [J]. CURRENT EYE RESEARCH, 1987, 6 (06) : 779 - 784
  • [4] GURNY R, 1987, Journal of Controlled Release, V6, P367, DOI 10.1016/0168-3659(87)90090-3
  • [5] NORN MS, 1981, ACTA OPHTHALMOL, V59, P587
  • [6] Polack FM., 1982, CORNEA, V1, P133
  • [7] Robinson J.R., 1989, STP PHARM, V5, P839
  • [8] GELRITE - A NOVEL, ION-ACTIVATED, INSITU GELLING POLYMER FOR OPHTHALMIC VEHICLES - EFFECT ON BIOAVAILABILITY OF TIMOLOL
    ROZIER, A
    MAZUEL, C
    GROVE, J
    PLAZONNET, B
    [J]. INTERNATIONAL JOURNAL OF PHARMACEUTICS, 1989, 57 (02) : 163 - 168
  • [9] SOLUBILIZATION OF TROPICAMIDE BY POLOXAMERS - PHYSICOCHEMICAL DATA AND ACTIVITY DATA IN RABBITS AND HUMANS
    SAETTONE, MF
    GIANNACCINI, B
    DELMONTE, G
    CAMPIGLI, V
    TOTA, G
    LAMARCA, F
    [J]. INTERNATIONAL JOURNAL OF PHARMACEUTICS, 1988, 43 (1-2) : 67 - 76
  • [10] SAND BB, 1989, ACTA OPHTHALMOL, V67, P181